You are here

vantictumab

Vantictumab Placed on Partial Clinical Hold by FDA Following Voluntary Halt by OncoMed

Yahoo/Globe Newswire

Sat, 06/14/14 - 09:22 am

OncoMed initiates second Phase 1b clinical trial of vantictumab

Yahoo/AP

Fri, 11/15/13 - 11:25 am

non-small cell lung cancer

OncoMed Pharmaceuticals Presents Updated Phase 1a Data in Advanced Solid Tumor Patients for the First-in-Class WNT-Pathway-Targeting Antibody Vantictumab (OMP-18R5) at the European Cancer Congress 2013

Yahoo/GlobeNewsWire

Sun, 09/29/13 - 01:32 pm

neuroendocrine tumors